PLEIOTROPIC EFFECTS OF GENES LINKED TO SCHIZOPHRENIA

与精神分裂症相关的基因的多效性

基本信息

  • 批准号:
    7032078
  • 负责人:
  • 金额:
    $ 60.8万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2006
  • 资助国家:
    美国
  • 起止时间:
    2006-02-01 至 2010-11-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): For many years this laboratory has focused intensively on characterizing schizophrenia-related traits (SRTs) as qualitative and quantitative phenotypes for schizophrenia. Three of these SRTs - thought disorder with schizophrenic features, eye tracking dysfunction and a craniofacial anomaly involving the frontonasal-maxilllary junction - stand out as especially probative for clarifying the neurobiological interpretation of schizophrenia susceptibility loci. Each of these traits has a much higher recurrence in relatives of schizophrenics than in schizophrenics. Moreover, unlike schizophrenia, which is generally thought to involve a number of co-acting genes, the family data on the SRTs are consistent with monogenic transmission models, and may therefore clarify the complex genetics of schizophrenia. The massive investment by NIMH in searching for genes for schizophrenia has resulted in an impressive number of promising candidate genes and chromosomal regions. Our progress in characterizing SRTs places us in an ideal position to determine whether any of these SRTs is linked to identified genes and "warm spot" regions for schizophrenia. We recognize, of course, that not all of the reported linkages will be replicable, but the probability is high that some of them are authentic, and the added cost of taking an inclusive view of the candidate loci is modest. Our power analyses show that the density of individuals affected with the SRTs in families of a schizophrenic proband is sufficiently high that, given a candidate locus associated with the SRT, the probability of our being able to detect that relationship is very high. If any of the genetic loci that have been linked to schizophrenia can be shown to be linked to any of the SRTs, it would open the way for building a neurobiological bridge between the disease phenotype and its genetic underpinnings, and it would add considerably to the confidence one can have in the reported linkages. Because of our laboratory's long involvement in investigating schizophrenia-related traits, the substantial number of families already acquired and thoroughly studied with respect to these traits and the expertise of our statistical and molecular genetics collaborators, our laboratory is uniquely positioned to carry out these studies.
描述(由申请人提供):多年来,该实验室一直专注于将精神分裂症相关性状(SRT)作为精神分裂症的定性和定量表型。其中三个SRT-思维障碍与精神分裂症的特点,眼跟踪功能障碍和颅面异常涉及额鼻-上颌交界处-站出来,特别是证明澄清精神分裂症易感基因座的神经生物学解释。这些特征中的每一个在精神分裂症患者的亲属中的复发率都比精神分裂症患者高得多。此外,与精神分裂症,这通常被认为是涉及一些共同作用的基因,SRT的家庭数据与单基因传播模型是一致的,因此可能澄清精神分裂症的复杂遗传学。NIMH在寻找精神分裂症基因方面的大量投资已经产生了令人印象深刻的有希望的候选基因和染色体区域。我们在表征SRT方面的进展使我们处于一个理想的位置,以确定这些SRT中的任何一个是否与已识别的基因和精神分裂症的“热点”区域有关。当然,我们认识到,并非所有已报道的连锁都是可复制的,但其中一些连锁是真实的可能性很高,并且对候选基因座采取包容性观点的额外成本是适度的。我们的力量分析表明,密度的个人影响与SRT在家庭中的精神分裂症先证者是足够高的,给定的候选位点与SRT,我们能够检测到这种关系的概率是非常高的。如果任何与精神分裂症相关的基因位点都能被证明与任何一种SRT相关,这将为在疾病表型及其遗传基础之间建立神经生物学桥梁开辟道路,并将大大增加人们对所报道的联系的信心。由于我们实验室长期参与调查精神分裂症相关性状,大量家庭已经获得并彻底研究了这些性状以及我们统计和分子遗传学合作者的专业知识,我们实验室具有独特的优势来开展这些研究。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DEBORAH L LEVY其他文献

DEBORAH L LEVY的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DEBORAH L LEVY', 18)}}的其他基金

Targeting a Genetic Mutation in Glycine Metabolism with D-Cycloserine
用 D-环丝氨酸靶向甘氨酸代谢中的基因突变
  • 批准号:
    8805873
  • 财政年份:
    2014
  • 资助金额:
    $ 60.8万
  • 项目类别:
Neurobiology of a Mutation in Glycine Metabolism in Psychotic Disorders
精神病中甘氨酸代谢突变的神经生物学
  • 批准号:
    8443634
  • 财政年份:
    2012
  • 资助金额:
    $ 60.8万
  • 项目类别:
Neurobiology of a Mutation in Glycine Metabolism in Psychotic Disorders
精神病中甘氨酸代谢突变的神经生物学
  • 批准号:
    8539520
  • 财政年份:
    2012
  • 资助金额:
    $ 60.8万
  • 项目类别:
Neurobiology of a Mutation in Glycine Metabolism in Psychotic Disorders
精神病中甘氨酸代谢突变的神经生物学
  • 批准号:
    8854200
  • 财政年份:
    2012
  • 资助金额:
    $ 60.8万
  • 项目类别:
PLEIOTROPIC EFFECTS OF GENES LINKED TO SCHIZOPHRENIA
与精神分裂症相关的基因的多效性
  • 批准号:
    7536095
  • 财政年份:
    2006
  • 资助金额:
    $ 60.8万
  • 项目类别:
PLEIOTROPIC EFFECTS OF GENES LINKED TO SCHIZOPHRENIA
与精神分裂症相关的基因的多效性
  • 批准号:
    7289393
  • 财政年份:
    2006
  • 资助金额:
    $ 60.8万
  • 项目类别:
PLEIOTROPIC EFFECTS OF GENES LINKED TO SCHIZOPHRENIA
与精神分裂症相关的基因的多效性
  • 批准号:
    7174618
  • 财政年份:
    2006
  • 资助金额:
    $ 60.8万
  • 项目类别:
PLEIOTROPIC EFFECTS OF GENES LINKED TO SCHIZOPHRENIA
与精神分裂症相关的基因的多效性
  • 批准号:
    7737376
  • 财政年份:
    2006
  • 资助金额:
    $ 60.8万
  • 项目类别:
PLEIOTROPIC EFFECTS OF GENES LINKED TO SCHIZOPHRENIA
与精神分裂症相关的基因的多效性
  • 批准号:
    7315378
  • 财政年份:
    2006
  • 资助金额:
    $ 60.8万
  • 项目类别:
PSYCHOLOGICAL STUDIES IN SCHIZOPHRENIA
精神分裂症的心理学研究
  • 批准号:
    6579948
  • 财政年份:
    2002
  • 资助金额:
    $ 60.8万
  • 项目类别:

相似海外基金

FAIRClinical: FAIR-ification of Supplementary Data to Support Clinical Research
FAIRClinical:补充数据的 FAIR 化以支持临床研究
  • 批准号:
    EP/Y036395/1
  • 财政年份:
    2024
  • 资助金额:
    $ 60.8万
  • 项目类别:
    Research Grant
Optimizing integration of veterinary clinical research findings with human health systems to improve strategies for early detection and intervention
优化兽医临床研究结果与人类健康系统的整合,以改进早期检测和干预策略
  • 批准号:
    10764456
  • 财政年份:
    2023
  • 资助金额:
    $ 60.8万
  • 项目类别:
The IDeA State Consortium for a Clinical Research Resource Center: Increasing Clinical Trials in IDeA States through Communication of Opportunities, Effective Marketing, and WorkforceDevelopment
IDeA 州临床研究资源中心联盟:通过机会交流、有效营销和劳动力发展增加 IDeA 州的临床试验
  • 批准号:
    10715568
  • 财政年份:
    2023
  • 资助金额:
    $ 60.8万
  • 项目类别:
The Mayo Clinic NeuroNEXT Clinical Research Site
梅奥诊所 NeuroNEXT 临床研究网站
  • 批准号:
    10743328
  • 财政年份:
    2023
  • 资助金额:
    $ 60.8万
  • 项目类别:
Addressing Underperformance in Clinical Trial Enrollments: Development of a Clinical Trial Toolkit and Expansion of the Clinical Research Footprint
解决临床试验注册表现不佳的问题:开发临床试验工具包并扩大临床研究足迹
  • 批准号:
    10638813
  • 财政年份:
    2023
  • 资助金额:
    $ 60.8万
  • 项目类别:
Improving Multicultural Engagement in Clinical Research through Partnership with Federally Qualified Health Centers and Community Health Worker Programs
通过与联邦合格的健康中心和社区卫生工作者计划合作,改善临床研究中的多元文化参与
  • 批准号:
    10823828
  • 财政年份:
    2023
  • 资助金额:
    $ 60.8万
  • 项目类别:
The Minnesota TMD IMPACT Collaborative: Integrating Basic/Clinical Research Efforts and Training to Improve Clinical Care
明尼苏达州 TMD IMPACT 协作:整合基础/临床研究工作和培训以改善临床护理
  • 批准号:
    10828665
  • 财政年份:
    2023
  • 资助金额:
    $ 60.8万
  • 项目类别:
Promoting a Culture Of Innovation, Mentorship, Diversity and Opportunity in NCI Sponsored Clinical Research: NCI Research Specialist (Clinician Scientist) Award Application of Janice M. Mehnert, M.D.
在 NCI 资助的临床研究中促进创新、指导、多样性和机会文化:Janice M. Mehnert 医学博士的 NCI 研究专家(临床科学家)奖申请
  • 批准号:
    10721095
  • 财政年份:
    2023
  • 资助金额:
    $ 60.8万
  • 项目类别:
Clinical Research Center for REstoration of NEural-based Function in the Real World (RENEW)
现实世界神经功能恢复临床研究中心 (RENEW)
  • 批准号:
    10795328
  • 财政年份:
    2023
  • 资助金额:
    $ 60.8万
  • 项目类别:
Mentoring Scientists for Careers in HIV Translational Clinical Research
指导科学家从事艾滋病毒转化临床研究
  • 批准号:
    10762827
  • 财政年份:
    2023
  • 资助金额:
    $ 60.8万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了